FAFGX | MRAEX | FAFGX / MRAEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 11 years | - |
Gain YTD | 21.910 | 11.369 | 193% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 290B | 46.4M | 625,000% |
Annual Yield % from dividends | 0.69 | 0.00 | - |
Returns for 1 year | 30.50 | 20.81 | 147% |
Returns for 3 years | 1.64 | -19.10 | -9% |
Returns for 5 years | N/A | -25.39 | - |
Returns for 10 years | N/A | 3.11 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PCBIX | 45.40 | -0.15 | -0.33% |
Principal MidCap Institutional | |||
TGVAX | 28.20 | -0.12 | -0.42% |
Thornburg International Equity A | |||
HNMGX | 6.11 | -0.03 | -0.49% |
Harbor Disruptive Innovation Retirement | |||
FRBRX | 161.82 | -0.94 | -0.58% |
Franklin Biotechnology Discovery R6 | |||
MFLLX | 12.16 | -0.16 | -1.30% |
Morgan Stanley Inst Inception R6 |